Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson’s disease model

被引：0
|
作者：
Rupsha Mondal
Chayan Banerjee
Sumangal Nandy
Moumita Roy
Joy Chakraborty
机构：
[1] CSIR-Indian Institute of Chemical Biology,
[2] Academy of Scientific and Innovative Research (AcSIR),undefined
来源：
Cell & Bioscience | / 13卷
关键词：
Dopamine toxicity; Mitochondrial fragmentation; Calcineurin; Parkinson’s disease; L-DOPA therapy; Dendritic spine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Tat-Frataxin protects dopaminergic neuronal cells against MPTP-induced toxicity in a mouse model of Parkinson's disease
    Kim, Mi Jin
    Kim, Dae Won
    Jeong, Hoon Jae
    Sohn, Eun Jeong
    Shin, Min Jea
    Ahn, Eun Hee
    Kwon, Soon Won
    Kim, Young Nam
    Kim, Duk-Soo
    Park, Jinseu
    Eum, Won Sik
    Hwang, Hyun Sook
    Choi, Soo Young
    BIOCHIMIE, 2012, 94 (11) : 2448 - 2456
  • [42] Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease
    Merims, Doron
    Giladi, Nir
    PARKINSONISM & RELATED DISORDERS, 2008, 14 (04) : 273 - 280
  • [43] Dihydromyricetin Protects Against Salsolinol-Induced Toxicity in Dopaminergic Cell Line: Implication for Parkinson's Disease
    Getachew, Bruk
    Csoka, Antonei B. B.
    Copeland, Robert L. L.
    Manaye, Kebreten F. F.
    Tizabi, Yousef
    NEUROTOXICITY RESEARCH, 2023, 41 (02) : 141 - 148
  • [44] Dihydromyricetin Protects Against Salsolinol-Induced Toxicity in Dopaminergic Cell Line: Implication for Parkinson’s Disease
    Bruk Getachew
    Antonei B. Csoka
    Robert L. Copeland
    Kebreten F. Manaye
    Yousef Tizabi
    Neurotoxicity Research, 2023, 41 : 141 - 148
  • [45] Rescuing defective vesicular trafficking protects against α-synuclein toxicity in cellular and animal models of Parkinson's disease
    Lashuel, Hilal A.
    Hirling, Harald
    ACS CHEMICAL BIOLOGY, 2006, 1 (07) : 420 - 424
  • [46] Tyrosinase exacerbates dopamine toxicity but is not genetically associated with Parkinson's disease
    Greggio, E
    Bergantino, E
    Carter, D
    Ahmad, R
    Costin, GE
    Hearing, VJ
    Clarimon, J
    Singleton, A
    Eerola, J
    Hellström, O
    Tienari, PJ
    Miller, DW
    Beilina, A
    Bubacco, L
    Cookson, MR
    JOURNAL OF NEUROCHEMISTRY, 2005, 93 (01) : 246 - 256
  • [47] Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson's disease
    Vercammen, Linda
    Van der Perren, Anke
    Vaudano, Elisabetta
    Gijsbers, Rik
    Debyser, Zeger
    Van den Haute, Chris
    Baekelandt, Veerle
    MOLECULAR THERAPY, 2006, 14 (05) : 716 - 723
  • [48] Exposure to varenicline protects against locomotor alteration in a MPTP mouse model of Parkinson's disease
    Ribeiro-Carvalho, A.
    Leal-Rocha, P. H.
    Isnardo-Fernandes, J.
    Araujo, U. C.
    Abreu-Villaca, Y.
    Filgueiras, C. C.
    Manhaes, A. C.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2021, 54 (12)
  • [49] Melatonin protects against neurobehavioral and mitochondrial deficits in a chronic mouse model of Parkinson's disease
    Patki, Gaurav
    Lau, Yuen-Sum
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2011, 99 (04) : 704 - 711
  • [50] Rapamycin protects the mitochondria against oxidative stress and apoptosis in a rat model of Parkinson's disease
    Jiang, Jianhua
    Jiang, Juean
    Zuo, Yuanyi
    Gu, Zhenlun
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2013, 31 (04) : 825 - 832
12345